Trait Information | |
Identifier | MONDO_0015263 |
Description | A genetically heterogeneous condition characterized by complete or incomplete right bundle branch block accompanied by ST elevation in leads V1-V3. There is a high incidence of ventricular arrhythmia that may result in sudden death. [NCIT: C142891] | Trait category |
Cardiovascular disease
|
Synonyms |
10 synonyms
|
Mapped terms |
13 mapped terms
|
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS000737 (PRS_BrS) |
PGP000144 | Tadros R et al. Eur Heart J (2019) |
Brugada syndrome | Brugada syndrome | 3 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000737/ScoringFiles/PGS000737.txt.gz |
PGS001779 (BRSprs) |
PGP000260 | Barc J et al. Nat Genet (2022) |
Brugada syndrome | Brugada syndrome | 21 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001779/ScoringFiles/PGS001779.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM001757 | PGS000737 (PRS_BrS) |
PSS000905| European Ancestry| 1,185 individuals |
PGP000144 | Tadros R et al. Eur Heart J (2019) |
Reported Trait: Ajmaline-induced Type I Brugada syndrome electrocardiogram | OR: 1.174 [1.138, 1.21] | — | — | — | — |
PPM001758 | PGS000737 (PRS_BrS) |
PSS000905| European Ancestry| 1,185 individuals |
PGP000144 | Tadros R et al. Eur Heart J (2019) |
Reported Trait: Ajmaline-induced Type I Brugada syndrome electrocardiogram | — | C-index: 0.68 [0.65, 0.71] | correlation coefficient (r): -0.14 | — | — |
PPM009271 | PGS001779 (BRSprs) |
PSS007680| European Ancestry| 359,017 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Supraventricular tachycardia | OR: 0.92 [0.89, 0.96] | — | p-value: 4e-05 | — | — |
PPM009270 | PGS001779 (BRSprs) |
PSS007675| European Ancestry| 359,017 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Conduction system disorder orbradyarrhythmia | OR: 1.06 [1.03, 1.08] | — | p-value: 4.63e-06 | — | — |
PPM009272 | PGS001779 (BRSprs) |
PSS007676| European Ancestry| 11,942 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: PQ interval | β: 2.69866 | — | p-value: 1.90e-45 | — | — |
PPM009273 | PGS001779 (BRSprs) |
PSS007677| European Ancestry| 11,566 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: P wave duration | β: 0.7576 | — | p-value: 5.32e-09 | — | — |
PPM009274 | PGS001779 (BRSprs) |
PSS007678| European Ancestry| 11,877 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: QRS complex duration | β: 1.23043 | — | p-value: 4.21e-55 | — | — |
PPM009268 | PGS001779 (BRSprs) |
PSS007671| European Ancestry| 359,017 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Atrial fibrillation or flutter | OR: 0.94 [0.92, 0.95] | — | p-value: 6.22e-13 | — | — |
PPM009269 | PGS001779 (BRSprs) |
PSS007672| European Ancestry| 359,017 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Atrioventricular conduction disorder | OR: 1.16 [1.1, 1.21] | — | p-value: 1.47e-09 | — | — |
PPM009275 | PGS001779 (BRSprs) |
PSS007679| European Ancestry| 11,893 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: QT interval | β: -1.56242 | — | p-value: 4.75e-16 | — | — |
PPM009266 | PGS001779 (BRSprs) |
PSS007673| European Ancestry| 2,469 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: SCN5A Mutation in Burgada syndrome cases | β: -0.45 | — | p-value: 2.10e-17 | — | — |
PPM009267 | PGS001779 (BRSprs) |
PSS007674| European Ancestry| 2,820 individuals |
PGP000260 | Barc J et al. Nat Genet (2022) |
Reported Trait: Brugada baseline or drug-induced type 1 ECG in Burgada syndrome cases | β: 0.18 | — | p-value: 2e-05 | — | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000905 | Intravenous ajmaline was administered at consecutive boluses of 10 mg/min. A 10-s ECG was recorded ∼1 min after each bolus using a GE Healthcare electrocardiograph. The test was stopped when the target dose of 1 mg/kg rounded up to the next 10 mg was reached, if ventricular arrhythmia occurred, or at the manifestation of a Type I BrS pattern, defined as an ST elevation >2 mm with a coved morphology in any lead among V1–V2 in the 2nd to 4th intercostal spaces.15 | — | 1,185 individuals | — | European | — | Amsterdam | — |
PSS007671 | An atrial tachyarrhythmia characterised by rapid (usually faster than 300 bpm), irregular and uncoordinated atrial impulse generation, usually manifesting on ECG with indistinct P-waves and an irregularly irregular ventricular response. | — | [
|
— | European | British | UKB | — |
PSS007672 | Disorder of the atrioventricular conduction system in which there is failure of all atrial impulses to propagate to the ventricle | — | [
|
— | European | British | UKB | — |
PSS007673 | Pathogenicity of rare variants in SCN5A identified in included BrS cases was centrally assessed using the American College of Medical Genetics and Genomics and Association of Molecular Pathology (ACMG/AMP) guidelines, using an adapted version of CardioClassifier incorporating a quantitative approach based on case-control analyses, as performed previously in hypertrophic cardiomyopathy genes, as well as a curated compendium of functional data. | — | [
|
— | European | Dutch, Belgian, German, British, Turkish, Italian, Spanish, Danish, French, Irish | NR | These samples overlap with the cases used in the score development |
PSS007674 | A type 1 Brugada Syndrome ECG was defined as a coved type ST elevation at baseline (spontaneous) or after a drug challenge test, in one or more leads in the right precordial leads V1 and/or V2 in the standard position (4th intercostal space) or in high positions (2nd or 3rd intercostal spaces). | — | [
|
— | European | Dutch, Belgian, German, British, Turkish, Italian, Spanish, Danish, French, Irish | NR | These samples overlap with the cases used in the score development |
PSS007675 | Disorder of the atrioventricular conduction system in which there is failure of all atrial impulses to propagate to the ventricle or Any of a number of possible arrhythmias originating from at or above the level of bundle of His in which the heart beats slower than the age-dependent lower limits of normal. | — | [
|
— | European | British | UKB | — |
PSS007676 | Electrocardiogram PQ interval | — | 11,942 individuals | — | European | British | UKB | — |
PSS007677 | Electrocardiogram P-wave duration | — | 11,566 individuals | — | European | British | UKB | — |
PSS007678 | Electrocardiogram QRS duration | — | 11,877 individuals | — | European | British | UKB | — |
PSS007679 | Electrocardiogram QT interval | — | 11,893 individuals | — | European | British | UKB | — |
PSS007680 | associated with episodes of atrial tachycardia | — | [
|
— | European | British | UKB | — |